Condition
Mitral Regurgitation (MR) clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Mitral Regurgitation (MR) clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Germany (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1New in 30 days
- 3Countries
Newest Mitral Regurgitation (MR) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Capstan TMVR Feasibility for Mitral Regurgitation | — | San Francisco, California and 2 other locations | Recruiting | Nov 4, 2026 |
| Transcatheter repair for atrial functional mitral regurgitation in high-risk patients | — | Beijing | Recruiting | Aug 3, 2026 |
| MitraFix transcatheter mitral valve system for high-risk severe mitral regurgitation | — | Beijing, Beijing Municipality | Recruiting | Mar 30, 2026 |
| DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease | — | New York, New York | Recruiting | Sep 29, 2025 |
| Segeberg registry for mitral clip (M-TEER) in severe mitral regurgitation | — | Bad Segeberg, Schleswig-Holstein | Recruiting | Jul 1, 2025 |
| Assessing risks and outcomes in patients with mitral regurgitation | — | Guangzhou, Guangdong | Recruiting | Mar 14, 2025 |
All recruiting trials (6)
-
Capstan TMVR Feasibility for Mitral Regurgitation
This early feasibility study tests the Capstan Compass Robotic System to replace the mitral valve in adults with symptomatic, moderate-to-severe or severe mitral regurgitation who aren’t candidates for surgical repair or standard edge-to-edge repair.
-
Transcatheter repair for atrial functional mitral regurgitation in high-risk patients
This trial tests whether adding a catheter-based mitral valve repair (TEER) to optimized medical therapy helps adults with atrial functional MR who are at high surgical risk.
-
MitraFix transcatheter mitral valve system for high-risk severe mitral regurgitation
This trial will test the MitraFix transcatheter mitral valve system to see if it can be safely implanted and reduce severe leaky mitral valves in adults at high risk for open-heart surgery.
-
DELINEATE-Prospective: AI-assisted echocardiogram analysis for valve disease
This project will test whether an AI system can automatically analyze echocardiograms to help doctors detect valve problems in adults who get heart ultrasounds.
-
Segeberg registry for mitral clip (M-TEER) in severe mitral regurgitation
This registry follows people with severe mitral regurgitation who get a mitral valve clip (M-TEER) at the Segeberg heart center to see how they do over time.
-
Assessing risks and outcomes in patients with mitral regurgitation
This study looks at patients with moderate to severe mitral regurgitation to see what factors might affect their health outcomes and help doctors make better treatment decisions.
Related topics
Quick answers
How many Mitral Regurgitation (MR) clinical trials are recruiting right now?
6, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.